Wardyński & Partners assisted with the sale of a Polish subsidiary of Strides Arcolab Limited
03.12.2016
At the end of February 2013, Strides Arcolab Limited (SAL), a pharmaceutical corporation based in Bangalore, divested some of its subsidiaries including a Polish company – Agila Specialties Polska sp. z o.o. – which operates one of SAL’s plants.
In the course of the transaction, an American company Mylan Inc purchased the target entities for USD 1.6 billion with an option to pay additional USD 250 million after SAL meets certain conditions stipulated in the transaction agreement.
The deal is regarded as one of the largest recent transactions on the pharmaceutical market.
Wardyński & Partners assisted in the transaction by drawing up a due diligence review report of Agila Specialties Polska sp. z o.o. and drafting a list of permits and authorizations necessary to conduct a pharmaceutical production business in Poland, that includes production of medicines. Moreover, our law firm assisted in preparing the agreement for sale of SAL companies inasmuch as it concerned the Polish target and verified the representations and warranties relevant thereto.
The Wardyński & Partners team was supervised by Weronika Pelc, one of the partners responsible at the firm for the M&A practice.
The following international law firms were also involved in the transaction: Herbert Smith Freehills as the leading law firm, DSK Legal, Haynes and Boone and Pinheiro Neto Advogados.